Learning Objectives:

1.  Outline risk factors for progression of Ph-negative MPNs to accelerated phase (AP) or blast phase (BP)

2.  Discuss outcomes with current treatment modalities in MPN-AP/BP

3.  Highlight novel therapeutic approaches in MPN-AP/BP with a focus on IDH inhibition

Session date: 
Monday, November 23, 2020 - 12:00pm to 1:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Anand A. Patel, MD